|
Name |
24-Hydroxylergosta-4,6,8(14),22-tetraen-3-one
|
| Molecular Formula | C28H40O2 | |
| IUPAC Name* |
(9R,10R,13R,17R)-17-[(2R)-5-hydroxy-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
|
|
| SMILES |
C[C@H](C=CC(C)(C(C)C)O)[C@H]1CCC2=C3C=CC4=CC(=O)CC[C@@]4([C@H]3CC[C@]12C)C
|
|
| InChI |
InChI=1S/C28H40O2/c1-18(2)28(6,30)16-11-19(3)23-9-10-24-22-8-7-20-17-21(29)12-14-26(20,4)25(22)13-15-27(23,24)5/h7-8,11,16-19,23,25,30H,9-10,12-15H2,1-6H3/t19-,23-,25+,26+,27-,28?/m1/s1
|
|
| InChIKey |
VCRVBLLMTMHOEY-BZABDROBSA-N
|
|
| Synonyms |
24-hydroxylergosta-4,6,8(14),22-tetraen-3-one
|
|
| CAS | NA | |
| PubChem CID | 139590508 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 408.6 | ALogp: | 5.6 |
| HBD: | 1 | HBA: | 2 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 37.3 | Aromatic Rings: | 4 |
| Heavy Atoms: | 30 | QED Weighted: | 0.537 |
| Caco-2 Permeability: | -4.989 | MDCK Permeability: | 0.00001670 |
| Pgp-inhibitor: | 1 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.915 |
| 30% Bioavailability (F30%): | 0.302 |
| Blood-Brain-Barrier Penetration (BBB): | 0.002 | Plasma Protein Binding (PPB): | 96.06% |
| Volume Distribution (VD): | 1.529 | Fu: | 2.26% |
| CYP1A2-inhibitor: | 0.052 | CYP1A2-substrate: | 0.568 |
| CYP2C19-inhibitor: | 0.442 | CYP2C19-substrate: | 0.936 |
| CYP2C9-inhibitor: | 0.522 | CYP2C9-substrate: | 0.164 |
| CYP2D6-inhibitor: | 0.455 | CYP2D6-substrate: | 0.176 |
| CYP3A4-inhibitor: | 0.933 | CYP3A4-substrate: | 0.906 |
| Clearance (CL): | 1.254 | Half-life (T1/2): | 0.477 |
| hERG Blockers: | 0.597 | Human Hepatotoxicity (H-HT): | 0.176 |
| Drug-inuced Liver Injury (DILI): | 0.103 | AMES Toxicity: | 0.014 |
| Rat Oral Acute Toxicity: | 0.097 | Maximum Recommended Daily Dose: | 0.901 |
| Skin Sensitization: | 0.955 | Carcinogencity: | 0.098 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.037 |
| Respiratory Toxicity: | 0.953 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003739 | ![]() |
0.822 | D0G8BV | ![]() |
0.339 | ||
| ENC004022 | ![]() |
0.780 | D0F1UL | ![]() |
0.339 | ||
| ENC001861 | ![]() |
0.780 | D04GJN | ![]() |
0.304 | ||
| ENC004737 | ![]() |
0.780 | D0Z1XD | ![]() |
0.300 | ||
| ENC003667 | ![]() |
0.761 | D06XMU | ![]() |
0.294 | ||
| ENC004998 | ![]() |
0.758 | D04ATM | ![]() |
0.291 | ||
| ENC003368 | ![]() |
0.755 | D06JPB | ![]() |
0.286 | ||
| ENC004834 | ![]() |
0.745 | D0I2SD | ![]() |
0.282 | ||
| ENC005009 | ![]() |
0.640 | D0W5LS | ![]() |
0.281 | ||
| ENC004736 | ![]() |
0.604 | D0N1TP | ![]() |
0.281 | ||